Scarica l'app Stockscreener
4.6198
1.31%
0.0598
Dopo l'orario di chiusura:
4.65
0.0302
+0.65%
Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - |
Operating Expenses
|
11.45%
1.3011
|
1.4693 | 2.2309 | 2.7805 |
| Depreciation and Amortization |
32.13%
0.00936
|
0.0138 | 0.00869 | 0.0153 |
| Operating Income/Loss |
11.45%
-1.3011
|
-1.4693 | -2.2309 | -2.7805 |
| Income/Loss From Continuing Operations Before Tax |
18.29%
-1.2259
|
-1.0363 | -2.2292 | -2.7757 |
| Income Tax Expense/Benefit |
-
|
- | - | - |
| Income/Loss From Continuing Operations After Tax |
18.29%
-1.2259
|
-1.0363 | -2.2292 | -2.7757 |
|
Net Income/Loss
|
18.29%
-1.2259
|
-1.0363 | -2.2292 | 2.7757 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | 5.5514 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
0.37%
2.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):